ArticleFrontiers in medicine2026
Biochip-simulated genotype signals enable accurate and interpretable AMR prediction via machine learning.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Phenotype-Guided Nanotherapeutic Strategies for Carbapenem-ResistantPharmaceutics · 2026Review
- Transforming Nanomaterials Development with Artificial Intelligence Techniques.Nanotechnology, science and applications · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Antimicrobial resistance (AMR) is an escalating global health crisis, driven by the rapid evolution of resistant pathogens and the limitations of traditional diagnostic methods. Current approaches such as culture-based techniques are time-intensive, while molecular methods demand specialized infrastructure. Objective: This study aims to develop a smart pathogen sensing framework using biochip-simulated genotypic signals combined with machine learning (ML) and explainable AI. The goal is to accurately predict AMR profiles while enabling model interpretability and personalized feedback through Agentic AI. Methods: From a publicly available dataset of over 400,000 real Results: The proposed Voting Classifier achieved superior multi-class prediction performance, with high accuracy, precision, recall, F1-score, and AUC across diverse resistance profiles. UMAP visualizations and silhouette scores confirmed robust clustering, while SHAP interpretation enhanced transparency by identifying key resistance genes. A rule-based recommendation system translated SHAP-ranked gene contributions into context-specific clinical insights, improving interpretability and practical usability. Comparative analysis with state-of-the-art studies highlighted the novelty and superiority of our biochip-integrated, explainable pipeline. Conclusion: This study presents a scalable, proof-of-concept diagnostic framework that integrates simulated biochip genotypes, interpretable ML models, and a rule-based recommendation system. By bridging predictive accuracy with actionable insights, the framework offers a pathway toward a potential pathway toward clinically relevant AMR diagnostics, advancing both computational innovation and practical decision support.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.